NEW

GE Healthcare Invests $50M in Wisconsin Facility

GE Healthcare has announced a $50 million investment in its existing West Milwaukee facility as part of its intention (proposal only; final decision to be made after required bargaining with relevant unions) to concentrate teams and resources in key facilities across...

New Version of c.cam Cardiac SPECT System Debuts in U.S.

Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total...

Physicians Highlight Potential of Radiopharmaceuticals in Oncology

The Medical Imaging & Technology Alliance (MITA), along with the Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) and the Society of Nuclear Medicine & Molecular Imaging (SNMMI), hosted a virtual briefing for Capitol Hill staff this month with...

Nanox Signs Agreement to Deploy 630 Units in Mexico

NANO-X IMAGING LTD, an innovative medical imaging technology company, announced that it has entered into an exclusive distribution agreement with SPI Medical (SPI) for the deployment and introduction of Nanox’s medical imaging services in Mexico. SPI Medical, S. A. P....

Public Meeting – Food and Drug Administration’s Communications About the Safety of Medical Devices

The U.S. Food and Drug Administration (FDA) has announced a public meeting entitled: Communications About the Safety of Medical Devices, which will be held on April 1, 2020.

During this meeting, we will:

  • Share the FDA’s current practices about medical device safety communications, including development, content, and format
  • Hear from our stakeholders—including patients, caregivers, health care providers, regulated industry, and the media—about how we can improve our safety communications to assure they receive the information they need in a timely, clear, and consistent manner.

Learn More

Important Deadlines

  • By March 4, 2020: Request special accommodations due to a disability
  • By March 18, 2020: Register to attend the meeting
  • By March 18, 2020: Request to make oral presentations
  • By June 1, 2020: Submit written comments to the docket (FDA-2020-N-0096)

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *